During an inspiring Endo Summit Live session dedicated to novel treatments for endometriosis, the founders of Sur180 Therapeutics, Drs. Annelyn Torres, Caroline Appleyard, and Idhaliz Flores, shared their journey from rigorous scientific research to the founding of a startup with a mission to revolutionize endometriosis care.
Dr. Annelyn Torres: From Research to Entrepreneurship
Dr. Annelyn Torres kickstarted the conversation with her transition from a researcher to an entrepreneur. She outlined the inception of Sur180 Therapeutics, emphasizing the startup’s focus on addressing the unmet needs of endometriosis patients through innovative, non-hormonal treatments. With a decade of research under her belt, Dr. Torres-Reverón’s passion for women’s health and advancing treatment options shines through Sur180’s vision.
Dr. Caroline Appleyard: The Science Behind Sur180
Dr. Caroline Appleyard took the stage to delve into the scientific foundations of their work. A clinical pharmacologist by training, she explained the importance of targeting stress-related mechanisms in endometriosis treatment. Dr. Appleyard discussed the pivotal role of the hypothalamic-pituitary-adrenal (HPA) axis in the disease’s progression and how Sur180’s therapeutic approach aims to modulate this system to alleviate symptoms and potentially halt disease progression.
Dr. Idhaliz Flores: Bridging Science and Patient Care
Dr. Idhaliz Flores, with nearly two decades of endometriosis research experience, highlighted the critical intersection of science and patient care. She shared insights into the therapeutic potential of addressing stress through environmental enrichment and pharmacological interventions. Dr. Flores passionately spoke about Sur180’s commitment to holistic care, emphasizing the importance of integrating lifestyle modifications and stress management alongside traditional medical treatments.
Sur180 Therapeutics: A New Horizon in Endometriosis Treatment
The founders’ presentations shed light on Sur180 Therapeutics’ pioneering approach to endometriosis treatment. By harnessing the power of scientific research and leveraging non-hormonal therapeutic strategies, Sur180 stands ready to offer new hope to millions of women worldwide affected by this condition. Their work represents a significant leap forward in endometriosis care, promising a future where comprehensive, patient-centered treatments become the norm.
sur180therapeutics.com 